[Change in lipid metabolism of the myocardium in experimental myocardial dystrophies and effect on that process of alpha- and beta-adrenoblockaders].
D000818:Animals; D003864:Depression, Chemical; D004558:Electric Stimulation; D007545:Isoproterenol / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D008049:Lipase / Q000032:analysis; D050356:Lipid Metabolism; D008055:Lipids / Q000032:analysis; D008297:Male; D009136:Muscular Dystrophies / Q000378:metabolism*; D009206:Myocardium / Q000032:analysis / Q000201:enzymology / Q000378:metabolism*; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology*
D008055:Lipids; D013565:Sympatholytics; D008049:Lipase; D007545:Isoproterenol; D009638:Norepinephrine
Izmenenie lipidnogo obmena serdechnoĭ myshtsy pri éksperimental'nykh distrofiiakh miokarda i vliianie na étot protsess al'fa-beta-adrenoblokatorov.